Goldenwell Biotech, Inc.
GWLL
$0.20
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.50K | -- | -200.00 | -- | 100.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.50K | -- | -200.00 | -- | 100.00 |
| Cost of Revenue | -- | -- | -100.00 | -- | 100.00 |
| Gross Profit | 37.50K | -- | -100.00 | -- | 100.00 |
| SG&A Expenses | 40.60K | 32.30K | 19.10K | 23.10K | 47.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.60K | 32.30K | 19.00K | 23.10K | 48.00K |
| Operating Income | -3.10K | -32.30K | -19.10K | -23.10K | -47.80K |
| Income Before Tax | -5.20K | -34.40K | -27.50K | -23.10K | -49.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.20K | -34.40K | -27.50K | -23.10K | -49.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.20K | -34.40K | -27.50K | -23.10K | -49.90K |
| EBIT | -3.10K | -32.30K | -19.10K | -23.10K | -47.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 96.43M | 99.00M | 106.70M | 96.43M | 96.43M |
| Average Diluted Shares Outstanding | 96.43M | 99.00M | 106.70M | 96.43M | 96.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |